The influence on long-term survey of the patients with acute promyelocytic leukemia treated alternatively with compound huangdai tablets and chemotherapy

Objective:To investigate the influence on long-term survey of the patients with acute promyelocytic leukemia treated alternatively with compound huangdai tablets and chemotherapy. Method:Sixty-two patients were treated alternatively with compound huangdai tablets and chemotherapy. Result:The median time of complete remission was 48 months. Among the patients who are followed-up and persistent to treat, 3- ,5- ,7 - and 10-year relapse-free survival (RFS)were 68. 41% ,48. 15% ,38. 89% ,18. 52% respectively, and 3-year survival probability was 88. 52% ,5- ,7 -and 10 -year survival probability were 86. 88%. Conclusion:Compound huangdai tablets and chemotherapy is an effective treatment protocol post-remission.